ストックスクリーナーアプリを入手
57.57
2.80%
1.57
前日終値:
$56.00
開ける：
$55.76
24時間の取引高:
773.29K
Relative Volume:
0.79
時価総額：
$1.57B
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-2.54%
1か月 パフォーマンス:
+23.33%
6か月 パフォーマンス:
+0.00%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$55.23
$58.11
1週間の範囲:
$50.29
$62.18
52週間の値動き範囲:
$33.42
$62.18
Hinge Health Inc Stock (HNGE) Company Profile
HNGE を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
HNGE
Hinge Health Inc
|
57.57 | 4.63B | 0 | 0 | 0 | 0.00 |
|
VEEV
Veeva Systems Inc
|
290.86 | 46.10B | 2.86B | 780.66M | 1.19B | 4.72 |
|
TEM
Tempus Ai Inc
|
80.52 | 13.63B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
67.74 | 12.35B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
89.82 | 7.74B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
36.24 | 6.32B | 906.14M | -52.62M | 89.62M | -0.3621 |
Hinge Health Inc Stock (HNGE) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-14 | 開始されました | Citizens JMP | Mkt Outperform |
| 2025-06-16 | 開始されました | Barclays | Overweight |
| 2025-06-16 | 開始されました | BofA Securities | Buy |
| 2025-06-16 | 開始されました | Canaccord Genuity | Buy |
| 2025-06-16 | 開始されました | Evercore ISI | Outperform |
| 2025-06-16 | 開始されました | KeyBanc Capital Markets | Overweight |
| 2025-06-16 | 開始されました | Morgan Stanley | Overweight |
| 2025-06-16 | 開始されました | Needham | Buy |
| 2025-06-16 | 開始されました | Piper Sandler | Overweight |
| 2025-06-16 | 開始されました | RBC Capital Mkts | Outperform |
| 2025-06-16 | 開始されました | Raymond James | Outperform |
| 2025-06-16 | 開始されました | Stifel | Buy |
| 2025-06-16 | 開始されました | Truist | Buy |
| 2025-06-16 | 開始されました | William Blair | Outperform |
すべてを表示
Hinge Health Inc (HNGE) 最新ニュース
Hinge Health (NYSE:HNGE) Sets New 12-Month HighTime to Buy? - MarketBeat
Hinge Health (NYSE:HNGE) Stock Price Up 5.7%Time to Buy? - MarketBeat
Piper Sandler raises Hinge Health stock price target to $70 on strong outlook - Investing.com
Hinge Health Announces Early Share Lock-Up Release - MSN
Hinge Health’s Strategic Initiatives and Growth Potential Drive Buy Rating - TipRanks
CCORF Maintains Hinge Health(HNGE.US) With Buy Rating, Maintains Target Price $61 - 富途牛牛
Hinge Health (NYSE:HNGE) Trading Down 7.1%Here's What Happened - MarketBeat
Digital health Q2 earnings: New guys win, GLP-1 companies lose - Modern Healthcare
Analysts Offer Insights on Healthcare Companies: Omada Health, Inc. (OMDA), Gilead Sciences (GILD) and Cytokinetics (CYTK) - The Globe and Mail
Baron Small Cap Fund is Excited to Invest in Hinge Health (HNGE). Here’s Why - Insider Monkey
Is hnge a buy sell or hold - AInvest
Hinge Health (NYSE:HNGE) Price Target Raised to $65.00 - MarketBeat
Hinge Health (NYSE:HNGE) Reaches New 12-Month High Following Analyst Upgrade - MarketBeat
Hinge Health (NYSE:HNGE) Stock Price Expected to Rise, Canaccord Genuity Group Analyst Says - MarketBeat
Hinge Health (NYSE:HNGE) Given New $60.00 Price Target at Evercore ISI - MarketBeat
Hinge Health (NYSE:HNGE) Price Target Raised to $59.00 - MarketBeat
Morgan Stanley Raises Hinge Health (NYSE:HNGE) Price Target to $57.00 - MarketBeat
Bank of America Forecasts Strong Price Appreciation for Hinge Health (NYSE:HNGE) Stock - MarketBeat
Hinge Health, Inc. Class A Common Stock (NYSE:HNGE) Stock Quote - FinancialContent
Hinge Health shares fall 1.26% intraday as Trump's import taxes raise economic concerns. - AInvest
Brokerages Set Hinge Health Inc. (NYSE:HNGE) Price Target at $49.86 - Defense World
Hinge Health Inc. (NYSE:HNGE) Given Average Rating of "Buy" by Analysts - MarketBeat
Morgan Stanley Forecasts Strong Price Appreciation for Hinge Health (NYSE:HNGE) Stock - Defense World
Barclays Boosts Hinge Health (NYSE:HNGE) Price Target to $62.00 - MarketBeat
Hinge Health price target raised to $62 from $48 at Truist - Yahoo Finance
Hinge Health’s Strategic Growth and Market Positioning: A Buy Recommendation by Ryan MacDonald - TipRanks
Hinge Health (NYSE:HNGE) Sets New 52-Week High on Analyst Upgrade - Defense World
Hinge Health: Is It Too Late to Buy? - timothysykes.com
Hinge Health’s Strong Growth and Margin Improvements Drive Buy Rating and Increased Price Objective - TipRanks
Hinge Health shares rise 23.34% intraday after RBC raised its price target to $60. - AInvest
TR | OpenAI4o Initiates Hinge Health(HNGE.US) With Hold Rating, Announces Target Price $52 - 富途牛牛
Hinge Health's Q2 Earnings Surge: A Case Study in Long-Term Value Creation Post-IPO - AInvest
Hinge Health Raises PT to $61 at Canaccord Genuity Maintains Buy Rating - AInvest
Hinge Health's Q2 Earnings: A Strategic Bet on AI-Driven Healthcare Automation - AInvest
Hinge Health Q2 beat: 'Long-term' thinking is key, CEO says - Yahoo Finance
Hinge Health's AI-Driven Surge: Redefining Digital Healthcare Profitability Post-IPO - AInvest
Hinge Health beats Wall Street expectations on revenue in first public earnings - Healthcare Dive
Hinge Health price target raised to $63 from $55 at Stifel - TipRanks
Hinge Health Climbs Amidst Strategic Acquisitions and Expanding Horizons - StocksToTrade
Hinge Health price target raised to $59 from $47 at Needham - TipRanks
Elevating Dynamics: Hinge Health’s Strategic Moves Stir Market Pattens - timothysykes.com
Hinge Health's Post-IPO Surge: Clinical Excellence and Employer Adoption Fuel a New Era in Digital MSK Care - AInvest
Hinge Health Gains in Market Debut, Providing a Favorable Sign for IPOs -- Update - 富途牛牛
Hinge Health Soars 22.7% on Q2 Earnings Surge: Can This AI-Powered Healthcare Play Sustain Momentum? - AInvest
Why are Hinge Health’s Shares Surging in Premarket Trading Today? - Tokenist
RBC Raises Price Target on Hinge Health to $60 From $45, Keeps Outperform Rating - MarketScreener
Hinge Health's Post-IPO Surge: A Test of Fundamentals in the Digital Therapeutics Gold Rush - AInvest
Hinge Health price target raised to $57 from $46 at Morgan Stanley - TipRanks
Stifel raises Hinge Health stock price target to $63 on strong Q2 results - Investing.com Nigeria
Hinge Health shares rise 7.84% premarket after Q2 2025 earnings call and revenue growth. - AInvest
Citizens JMP raises Hinge Health stock price target to $65 on strong earnings - Investing.com Australia
Hinge Health Inc (HNGE) 財務データ
Hinge Health Inc (HNGE) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
1.72%
0.81%
大文字化:
|
ボリューム (24 時間):